Alnylam building $100 million biotech facility, filling 150 jobs in Norton
BOSTON — Boston-area biotech Alnylam plans to build a new facility and add 150 jobs.
The company has pledged to have three marketed products and 10 clinical-stage candidates by 2020. With its recent decision to build a plant in the area, it is taking steps to ensure it has its own manufacturing operation to produce them.
The company last week closed its deal to buy a 12-acre site in Norton, MA, which is about 40 miles south of Alnylam headquarters in Cambridge, the Boston Globe reported. Christine Regan Lindenboom, VP of investor relations and communications, said Wednesday that construction is slated to begin in April and the 130,000-square-foot plant should be operational by 2018.
Alnylam has told investors it expects to spend about $100 million on the facility this year but has indicated that the total investment could eventually reach up to $200 million. The facility is slated to have 150 workers when it opens but the company has pledged to hire a total of 220 in 5 years. The drugmaker is getting about $7 million in tax breaks from the city.